This end of September, vision scientists and researchers from Harvard Medical SchoolHarvard Ophthalmology/Mass. Eye and Ear MEEI came together to discuss the latest topics in eye research, ranging from novel biomarkers and vascular pathogenesis to inflammation. The goal of this workshop is to accelerate innovative eye research using NHP research and hopefully to eradicate blinding diseases.
MEEI is an international center for treatment and research and a teaching hospital of Harvard Medical School. Ithas earned an international reputation for its successful treatment of the most difficult diseases and conditions of the eye, ear, nose, throat, and for its outstanding contributions to medical research and education.
Specific to age-related eye diseases, PriMed has established comprehensive characterization of ~1000 middle age/aged rhesus monkeys with clear pedigrees using fundus photography (FP) and optical coherence tomography (OCT) imaging with complete data analysis/ interpretation. PriMed’s monkeys with age-related eye diseases are potentially a powerful resource for eye diseaseresearch. We believe thisvaluable resource can be used not only to advance our understanding of the pathogenesis of age-related eye diseases, but to also accelerate the discovery of cures for blinding eye diseases such asage-related macular degeneration, glaucoma, and diabetic retinopathy.
SPEAKERS of the Workshop Committee include:
Dong Feng Chen, M.D., Ph.D.
Sunil Chauhan, Ph.D
Meredith Gregory-Ksander, Ph.D.
Kip Connor, Ph.D.
Tel : 028-8592-1823 (in China)
Tel : +86 (28) 8592-1823 (outside of China)
Fax : +86-28-62491302
Zip code : 610041